immunotherapy

• Among the Masses: Multiple Left Atrial Undifferentiated Pleomorphic Sarcomas

  Kevin Yager, Jerry Fan, Corry B. Sanford, Niloufar Pourfarrokh and Vinh Nguyen

  • Ochsner Journal December 2024, 24 (4) 279-283;
  • DOI: https://doi.org/10.31486/toj.23.0143

• Limitations to the Therapeutic Potential of Tyrosine Kinase Inhibitors and Alternative Therapies for Kidney Cancer

  Hossam Kamli, Li Li and Glenda C. Gobe

  • Ochsner Journal June 2019, 19 (2) 138-151;
  • DOI: https://doi.org/10.31486/toj.18.0015

• Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018

  Tanvir F. Kabir, Aman Chauhan, Lowell Anthony and Gerhard C. Hildebrandt

  • Ochsner Journal December 2018, 18 (4) 370-376;
  • DOI: https://doi.org/10.31486/toj.18.0055

• The Role of Checkpoint Inhibition in Non–Small Cell Lung Cancer

  Jonathan Lu and Robert A. Ramirez

  • Ochsner Journal December 2017, 17 (4) 379-387;

• Combination Immunotherapy for High-Risk Resected and Metastatic Melanoma Patients

  Adam I. Riker, Gabriela R. Rossi, Prerna Masih, L. C. Alsfeld, Fiona Denham, Lucinda Tennant, W. Jay Ramsey, Nicholas N. Vahanian and Charles J. Link

  • Ochsner Journal June 2014, 14 (2) 164-174;

• Malignant Melanoma of the Head and Neck: A Brief Review of Pathophysiology, Current Staging, and Management

  Christian Hasney, R. Brent Butcher and Ronald G. Amedee

  • Ochsner Journal December 2008, 8 (4) 181-185;